Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Neuronetics ( (STIM) ) has issued an update.
Neuronetics, Inc. and Greenbrook TMS Inc. have announced an interim order for their proposed all-stock transaction arrangement, which, pending satisfaction of conditions, will see Neuronetics acquire all issued and outstanding Greenbrook shares. The arrangement will result in Neuronetics and Greenbrook shareholders owning approximately 57% and 43% of the combined company, respectively. Both companies’ boards have unanimously approved the deal, which is subject to shareholder votes at upcoming special meetings. This move is anticipated to create a leading entity in the Transcranial Magnetic Stimulation market, offering non-invasive treatments for mental health disorders.
See more data about STIM stock on TipRanks’ Stock Analysis page.
